Case Report

A fatal side effect of piperacillin/tazobactam use: a case report.

Volume: 3 Number: 3 December 28, 2021
EN

A fatal side effect of piperacillin/tazobactam use: a case report.

Abstract

Drug-induced QT prolongation with T wave inversion is a complex regulatory and clinical problem due to the rarity of this potentially fatal adverse incident. A 68-year-old female patient was receiving piperacillin/tazobactam therapy for a complicated urinary tract infection. She has had normal ECG findings before the antibacterial therapy. After the treatment, the patient worsens due to long QT which is predisposed to torsades de pointes. As a result of the researches, it was understood that the cause of long QT was piperacillin/tazobactam. We aimed to present a rare case in which we detected drug-induced QTc prolongation with piperacillin/tazobactam in clinical practice.

Keywords

Supporting Institution

The authors declare no conflict of interest or any financial support.

References

  1. :1. Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol. 2006;17(3):333-336. doi:10.1111/j.1540-8167.2006.00408.x
  2. 2. Antzelevitch C, Shimizu W. Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol. 2002;17(1):43-51. doi:10.1097/00001573-200201000-00007
  3. 3. Woosley RL. QT Drug Lists by Risk Groups. AZ: Arizona Center for Research and Education on Therapeutics. Published 2009. Accessed September 1, 2021. http:// www.azcert.org/medical-pros/drug-lists/drug-lists.cfm
  4. 4. Katchman AN, Koerner J, Tosaka T, Woosley RL, Ebert SN. Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. J Pharmacol Exp Ther. 2006;316(3):1098-1106. doi:10.1124/jpet.105.093393
  5. 5. Poluzzi E, Raschi E, Motola D, Moretti U, De Ponti F. Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System. Drug Saf. 2010;33(4):303-314. doi:10.2165/11531850-000000000-00000
  6. 6. Panduranga P, Al-Mukhaini M, Rajarao MP. Multi-factorial causes of torsade de pointes in a hospitalised surgical patient. Sultan Qaboos Univ Med J. 2013;13(1):152-155. doi:10.12816/0003211
  7. 7. Piperacillin and tazobactam: Drug information. Published December 6, 2020. Accessed semtember 1, 2021. . https://www.uptodate.com/contents/piperacillin-and-tazobactam-drug-information search=piperacillin%20tazobactam&source=panel_search_result&selectedTitle=1~104&usage_type=panel&kp_tab=drug_general&display_rank=1#F210382

Details

Primary Language

English

Subjects

Intensive Care

Journal Section

Case Report

Publication Date

December 28, 2021

Submission Date

September 8, 2021

Acceptance Date

November 8, 2021

Published in Issue

Year 2021 Volume: 3 Number: 3

APA
Duyan, M., Günlü, S., Sarıdaş, A., Cander, B., & Solaç, Y. (2021). A fatal side effect of piperacillin/tazobactam use: a case report. Eurasian Journal of Critical Care, 3(3), 119-121. https://izlik.org/JA97WU47AK
AMA
1.Duyan M, Günlü S, Sarıdaş A, Cander B, Solaç Y. A fatal side effect of piperacillin/tazobactam use: a case report. Eurasian j Crit Care. 2021;3(3):119-121. https://izlik.org/JA97WU47AK
Chicago
Duyan, Murat, Serhat Günlü, Ali Sarıdaş, Basar Cander, and Yıldızhan Solaç. 2021. “A Fatal Side Effect of Piperacillin Tazobactam Use: A Case Report”. Eurasian Journal of Critical Care 3 (3): 119-21. https://izlik.org/JA97WU47AK.
EndNote
Duyan M, Günlü S, Sarıdaş A, Cander B, Solaç Y (December 1, 2021) A fatal side effect of piperacillin/tazobactam use: a case report. Eurasian Journal of Critical Care 3 3 119–121.
IEEE
[1]M. Duyan, S. Günlü, A. Sarıdaş, B. Cander, and Y. Solaç, “A fatal side effect of piperacillin/tazobactam use: a case report”., Eurasian j Crit Care, vol. 3, no. 3, pp. 119–121, Dec. 2021, [Online]. Available: https://izlik.org/JA97WU47AK
ISNAD
Duyan, Murat - Günlü, Serhat - Sarıdaş, Ali - Cander, Basar - Solaç, Yıldızhan. “A Fatal Side Effect of Piperacillin Tazobactam Use: A Case Report”. Eurasian Journal of Critical Care 3/3 (December 1, 2021): 119-121. https://izlik.org/JA97WU47AK.
JAMA
1.Duyan M, Günlü S, Sarıdaş A, Cander B, Solaç Y. A fatal side effect of piperacillin/tazobactam use: a case report. Eurasian j Crit Care. 2021;3:119–121.
MLA
Duyan, Murat, et al. “A Fatal Side Effect of Piperacillin Tazobactam Use: A Case Report”. Eurasian Journal of Critical Care, vol. 3, no. 3, Dec. 2021, pp. 119-21, https://izlik.org/JA97WU47AK.
Vancouver
1.Murat Duyan, Serhat Günlü, Ali Sarıdaş, Basar Cander, Yıldızhan Solaç. A fatal side effect of piperacillin/tazobactam use: a case report. Eurasian j Crit Care [Internet]. 2021 Dec. 1;3(3):119-21. Available from: https://izlik.org/JA97WU47AK